Registry update — unassessed
Investigation of the Effect of Exercise Training in Patient With Sarcopenic Multiple Sclerosis
Trial registry update: COMPLETED. No results reported in the supplied registry record.
RCTMinor significance
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Sep 18, 2026 · Discovered: Sep 18, 2026 · Assessed: — · Research update
What it does not prove
- The abstract contains no reported outcomes or effect estimates, so efficacy of exercise for any of the three endpoints cannot be determined from this document.
- Sample size, participant characteristics, and baseline demographics are not provided, limiting assessment of study power and generalizability.
- No comparison group or control condition is described, making it unclear whether this is a single-arm study or an RCT with both arms represented in this excerpt.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Rct
- Sample size
- —
- Duration
- 2 months
- Population
- Patients with sarcopenic multiple sclerosis
- Primary outcome
- Muscle thickness in sarcopenic MS patients
- Effect size
- —
- Significance
- Not reported
- Journal
- Uskudar University
- Published
- Sep 18, 2026
Sources
Primary source
- Uskudar University ↗Clinical trial
Recorded source passages
Abstract or registry material supplied for assessment; source version 2. This is not a claim of full-text review.
The aim of this clinical trial is exercise in sarcopenic MS patients to demonstrate the effectiveness of education.
They will continue combined exercise applications 3 days a week for 8 weeks. Evaluations will be made before the application and at the end of the 8 weeks. The data will be analyzed afterwards.
The main questions it aims to answer are: -Can exercise training make a change in muscle thickness in sarcopenic MS patients? --Does exercise training have an effect on balance in sarcopenic MS patients? - Does exercise training have an effect on the risk of falling in sarcopenic MS patients?
Source versions
Assessment history
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
Sign in to join the discussion.
No comments yet
Be the first to weigh in on this evidence.